Gilead Sciences, Inc. (GILD)
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Recs
donsguesswork
(31.02)
Submitted: 11/26/2009 11:48:15 AM :
Start Price:
$46.00
GILD Score:
+0.14
Gilead and GlaxoSmithKline have signed an agreement to commercialize Viread(R) doe treatment of Hepatitis B in five countries in Asia. In latest quarter Eps rose 31% and the stock went the next day.Analyst forecast 4th qtr eps of .81 up 35%.
Recs
a2investments
(40.80)
Submitted: 11/23/2009 11:42:38 PM :
Start Price:
$47.13
GILD Score:
+0.08
Highest quality growth. The revenue chart is a thing of beauty. Very high ROE.
Recs
kcjimbo
(71.14)
Submitted: 11/17/2009 8:38:48 PM :
Start Price:
$47.27
GILD Score:
+0.02
Blue chipper in a growth market.
Recs
BLAYNE100
(87.72)
Submitted: 11/16/2009 8:46:42 PM :
Start Price:
$47.29
GILD Score:
-0.33
Strong Sector for 2010
Recs
Inteljumper
(43.67)
Submitted: 11/16/2009 8:21:56 PM :
Start Price:
$47.26
GILD Score:
-0.37
A review ot this stock's performance shows there is a lot of speculative traders involved. This stock could burst through and skyrocket or fall flat on its face. A hard one to call, a bit of a gamble...especially with the uncertainty of Obama Care.
Recs
scoobamang
(88.43)
Submitted: 11/7/2009 3:19:09 PM :
Start Price:
$46.43
GILD Score:
-1.22
Increasing revenue and profit and close enough to a 52 week low.
Recs
881500
(87.63)
Submitted: 11/2/2009 10:03:55 PM :
Start Price:
$42.43
GILD Score:
+4.11
I like the statistics about this company, a good margin, effective management numbers good roi and roic, i dont see a lot not to like, except that it operates from within the veil of the great OZ (or one of them) the FDA) haha.
Recs
sccoast1700
(< 20)
Submitted: 10/30/2009 9:23:55 PM :
Start Price:
$42.96
GILD Score:
+3.16
A recession proof business. Leader in HIV /Aids treatment.Good products in the works for hypertension, liver fibrosis, and chrohic hepatitis c. Solid balance sheet.
Recs
Bawls
(60.21)
Submitted: 10/29/2009 3:17:45 PM :
Start Price:
$42.82
GILD Score:
+6.01
This stock unfortunately gets punished every time it reports strong profits, the recovers......
Recs
mitleg
(< 20)
Submitted: 10/27/2009 9:27:37 PM :
Start Price:
$43.09
GILD Score:
+4.83
This stock has languished while other sectors have driven the market. It is relatively inexpensive at the moment. Low peg, favorable pe, strong growth, low debt, and strong free cash flow. Given the connection to tamiflu, I think as swine flu continues to terrorize here in the midwest and elsewhere, it could have a real strong quarter or two.
Recs
21popsontop
(69.69)
Submitted: 10/26/2009 11:26:24 PM :
Start Price:
$43.43
GILD Score:
+4.83
I'm not much into purchasing the large and mega caps because a double is most likely the top of the run even for a growth machine like this one, and I'm also addicted to the longshots, but for the simple man just looking to turn a profit. Here she is. Buy $30 to $35 it most likely won't add very many points in your caps account as it slowly rises in dollars to the $50 or $60 range because caps does not register points from dollar gains but more so from daily S&P gains or losses compared to the stock.Bought the stock myself Feb 2005 for $17 and held it until may 2008 and it grew like grass. Even as big as it is,still growing like a tree.Beat est 6 out of the last 8 calls and estimates were increased 10/24/09. 2nd quarter 2009 rang in above 38% compared to last years 2nd quarter. P/E 17.00 Forward P/E 14.00 ,PEG 1.0 ,5 year sales growth 43% ,Gross Margins 77.00% , Net Profit Margins 37.00% ,ROE 47.00 Dept/Equity Ratio very low 0, Free cash flow superb. Company already upped full year 2009 guidance on both sales and revenue. I fully invested else where early part of this year and own no shares of this monster anymore,but for those still looking. You may want to give this one a hard look and catch it on the dip.
Recs
ryanman000
(99.13)
Submitted: 10/26/2009 8:48:44 PM :
Start Price:
$43.43
GILD Score:
+4.83
Solid Company, Unique Product Offering, missed general market rise off lows.
Recs
TalibKweli
(< 20)
Submitted: 10/20/2009 1:53:41 PM :
Start Price:
$46.35
GILD Score:
-0.21
Innovation...superior.
Recs
TomsRiver
(< 20)
Submitted: 9/28/2009 6:47:08 PM :
Start Price:
$47.01
GILD Score:
-3.83
An excellent bio-tech with product out there gaining in revenue while research continues into crucial health care needs.
Balance sheet,Free Cash Flow,Income and Net will continue to improve.
Recs
tagestief
(27.40)
Submitted: 9/21/2009 11:50:01 AM :
Start Price:
$46.28
GILD Score:
-2.34
sector change. gold is out. biotech in!
Recs
FinanceGuy58
(27.55)
Submitted: 9/17/2009 9:01:03 PM :
Start Price:
$45.71
GILD Score:
-0.56
I've owned it since the early 1990's and its been one of my best investments of all time. I used to think it would get acquired by a major pharma.....but now it is one!
Recs
cayamax
(< 20)
Submitted: 9/10/2009 3:33:47 PM :
Start Price:
$46.10
GILD Score:
-4.51
One of the best houses in a good neighborhood.
Recs
ice23bear
(27.98)
Submitted: 8/27/2009 4:31:50 PM :
Start Price:
$44.61
GILD Score:
-2.46
Tamiflu, good profit growth. Even the last two quarters are up slightly over the previous two.
Recs
cashandgrab
(75.54)
Submitted: 8/20/2009 4:54:37 PM :
Start Price:
$46.39
GILD Score:
-7.78
has the management and ability to move-up.
Recs
mrbunnyman
(< 20)
Submitted: 8/18/2009 11:45:09 PM :
Start Price:
$42.41
GILD Score:
+5.84
Global need, great RoE, profit margins and cash flow. Makes Tamiflu for treatment of Swine Flu and other drugs for treatment of life threatening infectious diseases including AIDS. Global provider of its medications including the W.H.O. Works with all the top Pharmaceutical companies in its R&D. Should outpace S&P by 60% on average.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 217 1 2 3 4 5 6 7 8 9 10 Next »